MGMT and glioblastoma: Patients with an MGMT promoter‐methylated (MGMT‐methylated) GBM receiving TMZ had a significantly longer median OS of up to 31.4 months [33, 39, 40, 41] compared to approximately 17 months in patients without MGMT promoter methylation (MGMT‐unmethylated) [42].